{"disease":{"id":"symptomatic","name":"symptomatic"},"drugs":{"marketed":[{"drug_id":"valsartan","indication_name":"Symptomatic heart failure in pediatric patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diovan","generic_name":"VALSARTAN","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker [EPC]","quality_score":10,"revenue":"447","mechanism":"Diovan works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure."},{"drug_id":"selumetinib","indication_name":"Neurofibromatosis Type 1 with Symptomatic, Inoperable Plexiform Neurofibromas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Koselugo","generic_name":"selumetinib","company_name":"ASTRAZENECA LP","drug_phase":"marketed","molecular_target":"AP2-associated protein kinase 1","drug_class":"Kinase Inhibitor [EPC]","quality_score":75,"revenue":null,"mechanism":"Selumetinib is an inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK1/2)."},{"drug_id":"fragmin","indication_name":"Extended Treatment of Symptomatic VTE in Adult Patients with Cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fragmin","generic_name":"Dalteparin Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Factor Xa and thrombin","drug_class":"Low molecular weight heparin (LMWH)","quality_score":68,"revenue":null,"mechanism":"Dalteparin enhances inhibition of Factor Xa and thrombin by antithrombin."},{"drug_id":"fragmin","indication_name":"Treatment of Symptomatic VTE in Pediatric Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fragmin","generic_name":"Dalteparin Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Factor Xa and thrombin","drug_class":"Low molecular weight heparin (LMWH)","quality_score":68,"revenue":null,"mechanism":"Dalteparin enhances inhibition of Factor Xa and thrombin by antithrombin."},{"drug_id":"enalapril-maleate","indication_name":"Symptomatic Congestive Heart Failure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"ENALAPRIL MALEATE","company_name":"Azurity","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor","quality_score":67,"revenue":null,"mechanism":"Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"enalapril-maleate","indication_name":"Asymptomatic Left Ventricular Dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"ENALAPRIL MALEATE","company_name":"Azurity","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor","quality_score":67,"revenue":null,"mechanism":"Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"dexamethasone-phosphate","indication_name":"Symptomatic Sarcoidosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"chembl-chembl1219","indication_name":"Treatment of Symptomatic GERD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"RABEPRAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":33,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl1219","indication_name":"Treatment of Symptomatic GERD in Adolescents","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"RABEPRAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":33,"revenue":null,"mechanism":null},{"drug_id":"homatropine-methylbromide","indication_name":"Symptomatic relief of cough","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"HOMATROPINE METHYLBROMIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"calcitonin","indication_name":"Symptomatic Paget's disease of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Osteobios","generic_name":"CALCITONIN","company_name":"Sanofi Aventis Us","drug_phase":"marketed","molecular_target":"calcitonin receptor","drug_class":"Calcitonin [EPC]","quality_score":70,"revenue":null,"mechanism":"Calcitonin salmon acts as a calcitonin receptor agonist, primarily affecting bone, with additional effects on the kidneys and gastrointestinal tract."},{"drug_id":"terazosin-hydrochloride","indication_name":"Symptomatic Benign Prostatic Hyperplasia (BPH)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TERAZOSIN HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"xarelto","indication_name":"Prevention of atherothrombotic events in symptomatic peripheral artery disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xarelto","company_name":"University Hospital, Montpellier","drug_phase":"marketed","molecular_target":"Suppressor of tumorigenicity 14 protein, Coagulation factor X, Coagulation factor X","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"benzylpenicillin","indication_name":"Asymptomatic Congenital Syphilis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Penicillin G Potassium In Plastic Container","generic_name":"Benzylpenicillin","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Penicillin-class Antibacterial","quality_score":32,"revenue":null,"mechanism":""},{"drug_id":"enalapril-maleate","indication_name":"Asymptomatic left ventricular systolic dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"ENALAPRIL MALEATE","company_name":"Azurity","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"Angiotensin Converting Enzyme Inhibitor","quality_score":67,"revenue":null,"mechanism":"Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"selumetinib","indication_name":"Treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Koselugo","generic_name":"selumetinib","company_name":"ASTRAZENECA LP","drug_phase":"marketed","molecular_target":"AP2-associated protein kinase 1","drug_class":"Kinase Inhibitor [EPC]","quality_score":75,"revenue":null,"mechanism":"Selumetinib is an inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK1/2)."},{"drug_id":"rivaroxaban","indication_name":"Prevention of atherothrombotic events in symptomatic peripheral artery disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xarelto","generic_name":"rivaroxaban","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Factor Xa (FXa)","drug_class":"Direct Factor Xa Inhibitor","quality_score":71,"revenue":null,"mechanism":"Selective FXa inhibitor that decreases thrombin generation without requiring cofactors."},{"drug_id":"fragmin","indication_name":"Extended treatment of symptomatic venous thromboembolism to reduce recurrence in adult patients with cancer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fragmin","generic_name":"Dalteparin Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Factor Xa and thrombin","drug_class":"Low molecular weight heparin (LMWH)","quality_score":68,"revenue":null,"mechanism":"Dalteparin enhances inhibition of Factor Xa and thrombin by antithrombin."},{"drug_id":"fragmin","indication_name":"Treatment of symptomatic venous thromboembolism to reduce recurrence in pediatric patients from birth (gestational age at least 35 weeks)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fragmin","generic_name":"Dalteparin Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Factor Xa and thrombin","drug_class":"Low molecular weight heparin (LMWH)","quality_score":68,"revenue":null,"mechanism":"Dalteparin enhances inhibition of Factor Xa and thrombin by antithrombin."},{"drug_id":"diazepam-2mg-encapsulated-tab","indication_name":"Symptomatic relief of acute alcohol withdrawal","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diazepam 2Mg encapsulated Tab","company_name":"The University of Hong Kong","drug_phase":"marketed","molecular_target":"GABA-A receptor (allosteric modulator)","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"enalapril","indication_name":"Asymptomatic left ventricular systolic dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"enalapril","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme, Angiotensin-converting enzyme","drug_class":"ACE inhibitor","quality_score":60,"revenue":null,"mechanism":"ACE inhibitor prodrug that is converted to enalaprilat, blocking angiotensin-converting enzyme to lower blood pressure."},{"drug_id":"enalaprilat","indication_name":"Asymptomatic left ventricular systolic dysfunction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasotec","generic_name":"ENALAPRILAT","company_name":"Biovail Labs Intl","drug_phase":"marketed","molecular_target":"Angiotensin-converting enzyme","drug_class":"enalaprilat","quality_score":75,"revenue":null,"mechanism":"Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor."},{"drug_id":"vimseltinib","indication_name":"symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Romvimza","generic_name":"VIMSELTINIB","company_name":"Deciphera Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Kinase Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Romvimza works by blocking a specific enzyme that helps cancer cells grow and survive."},{"drug_id":"prednisone","indication_name":"Symptomatic sarcoidosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"penicillin","indication_name":"Asymptomatic Congenital Syphilis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"penicillin","company_name":"Karlstad University","drug_phase":"marketed","molecular_target":"Bacterial penicillin-binding protein, Beta-lactamase, Beta-lactamase TEM","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":25,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03847753","title":"Exploring the Comorbidity Between Mental Disorders and General Medical Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":5940299,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT04701177","title":"Digitally-enhanced, Decentralized, Multi-omics Observational Cohort","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100000,"lead_sponsor_name":"Greece 2021 Committee","has_results":false},{"nct_id":"NCT04289753","title":"Behavioral Economics Applications to Geriatrics Leveraging EHRs R33 Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":37134,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT06968533","title":"ECG Low Ejection Fraction Detection and Guiding in AI Navigated Treatment Era","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":13350,"lead_sponsor_name":"National Defense Medical Center, Taiwan","has_results":false},{"nct_id":"NCT07389057","title":"Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana","phase":"NA","overall_status":"RECRUITING","enrollment_count":9000,"lead_sponsor_name":"Noguchi Memorial Institute for Medical Research","has_results":false},{"nct_id":"NCT06395675","title":"Clinical Evaluation of the ID NOW™ CT/NG Test","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":7100,"lead_sponsor_name":"Abbott Rapid Dx","has_results":false},{"nct_id":"NCT04367740","title":"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":6313,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT04301531","title":"Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in Ghana","phase":"NA","overall_status":"COMPLETED","enrollment_count":5861,"lead_sponsor_name":"Noguchi Memorial Institute for Medical Research","has_results":false},{"nct_id":"NCT03098290","title":"IDOMENEO - Is Treatment Reality in Vascular Medicine Evidence-based and Follows Guideline Recommendations? A Project for Quality Development Exemplified by Peripheral Arterial Disease (PAD)","phase":"","overall_status":"COMPLETED","enrollment_count":5608,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT07119918","title":"PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":5276,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04167566","title":"Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Noguchi Memorial Institute for Medical Research","has_results":false},{"nct_id":"NCT07156344","title":"Assessing Vulnerability and Outcomes of Intracranial Atherosclerotic Plaques","phase":"","overall_status":"COMPLETED","enrollment_count":3849,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT05282082","title":"Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.","phase":"","overall_status":"COMPLETED","enrollment_count":2105,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04363684","title":"ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)","phase":"","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07213778","title":"REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT02933489","title":"Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1516,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":true},{"nct_id":"NCT02664649","title":"Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1510,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06290076","title":"A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT05787444","title":"Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"LumiraDx UK Limited","has_results":false},{"nct_id":"NCT03445312","title":"Safety and Effectiveness of a Laboratory Intervention to Effectively NOT Treat Asymptomatic Bacteriuria","phase":"","overall_status":"COMPLETED","enrollment_count":1394,"lead_sponsor_name":"Mount Sinai Hospital, Canada","has_results":false},{"nct_id":"NCT04344197","title":"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"University of Rome Tor Vergata","has_results":false},{"nct_id":"NCT04091048","title":"Optimize PRO Study","phase":"","overall_status":"COMPLETED","enrollment_count":1127,"lead_sponsor_name":"Medtronic Cardiovascular","has_results":true},{"nct_id":"NCT03222128","title":"PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate","phase":"NA","overall_status":"COMPLETED","enrollment_count":1074,"lead_sponsor_name":"Edwards Lifesciences","has_results":true},{"nct_id":"NCT04039711","title":"Evaluation of Vaginal Self-sampling Diagnostic Performances to Identify Genital Infections","phase":"NA","overall_status":"COMPLETED","enrollment_count":1028,"lead_sponsor_name":"Hôpital Européen Marseille","has_results":false},{"nct_id":"NCT03752866","title":"CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat Patients With Severe Aortic Stenosis.","phase":"NA","overall_status":"COMPLETED","enrollment_count":1001,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT07196397","title":"POLish Registry of CArdioneuroablation and CArdioneuromodulation","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"SABAMED Medical Center Ltd.","has_results":false},{"nct_id":"NCT05040659","title":"Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT07459387","title":"REal-world Valued Outcomes of a noveL Balloon-in-basket pUlsed Field ablaTION Catheter for Atrial Fibrillation RegistrY","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Cardioangiologisches Centrum Bethanien","has_results":false},{"nct_id":"NCT05960084","title":"Impact of Reducing Colistin Use on Colistin Resistance in Humans and Poultry in Indonesia","phase":"","overall_status":"UNKNOWN","enrollment_count":803,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT07494864","title":"Effects of Microbiological and Immunological Factors on the Lower Urinary Tract","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT03648411","title":"Drug Resistance Among Asymptomatic Infection","phase":"","overall_status":"COMPLETED","enrollment_count":765,"lead_sponsor_name":"Department of Medical Research, Lower Myanmar","has_results":false},{"nct_id":"NCT04333160","title":"Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":746,"lead_sponsor_name":"Bone Therapeutics S.A","has_results":false},{"nct_id":"NCT03704389","title":"Behavioral Economics Applications to Geriatrics Leveraging EHRs","phase":"NA","overall_status":"COMPLETED","enrollment_count":664,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT05831098","title":"Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT","phase":"NA","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"MedMira Laboratories Inc.","has_results":false},{"nct_id":"NCT04665193","title":"An Approach to Screening for COVID-19 at Vancouver Airport","phase":"NA","overall_status":"COMPLETED","enrollment_count":592,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT04896710","title":"COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample","phase":"NA","overall_status":"UNKNOWN","enrollment_count":569,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT02184442","title":"The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B","phase":"NA","overall_status":"COMPLETED","enrollment_count":560,"lead_sponsor_name":"Edwards Lifesciences","has_results":true},{"nct_id":"NCT01543490","title":"Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":558,"lead_sponsor_name":"Sun Pharmaceutical Industries Limited","has_results":true},{"nct_id":"NCT02569398","title":"An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":557,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT02843529","title":"Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)","phase":"NA","overall_status":"COMPLETED","enrollment_count":548,"lead_sponsor_name":"Altoida","has_results":true},{"nct_id":"NCT02424370","title":"Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation","phase":"","overall_status":"COMPLETED","enrollment_count":515,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06360289","title":"Observational Study of Neurofilament Light Chain (NfL) as a Biomarker in Asymptomatic Carriers of the Transthyretin (TTR) Variants and Patients With Hereditary Transthyretin-mediated (hATTR) Amyloidosis With Polyneuropathy","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Alnylam Pharmaceuticals","has_results":false},{"nct_id":"NCT04694859","title":"Romanian National Registry of Outcomes After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis - RO-TAVI","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Romanian Society of Cardiology","has_results":false},{"nct_id":"NCT07058831","title":"Subclinical Atrial Fibrillation Home Monitoring in Hypertensive Patients","phase":"","overall_status":"RECRUITING","enrollment_count":499,"lead_sponsor_name":"Cardiovascular Research Center Rosario British Sanatorium","has_results":false},{"nct_id":"NCT03274960","title":"Screening and Treating Asymptomatic Bacteriuria Every Trimester and Preterm Birth","phase":"NA","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"University of Zimbabwe","has_results":false},{"nct_id":"NCT02586623","title":"Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":453,"lead_sponsor_name":"H. Lundbeck A/S","has_results":true},{"nct_id":"NCT06315023","title":"The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Endologix","has_results":false},{"nct_id":"NCT05398705","title":"Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT05293418","title":"Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":435,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT04788888","title":"Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":434,"lead_sponsor_name":"Abbott Medical Devices","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}